|Combination adjuvants: the next generation of adjuvants?|
G Mutwiri, V Gerdts, S van Drunen Littel-van den Hurk, G Auray, N Eng, ...
Expert review of vaccines 10 (1), 95-107, 2011
|Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis|
S Garlapati, NF Eng, TG Kiros, J Kindrachuk, GK Mutwiri, REW Hancock, ...
Vaccine 29 (38), 6540-6548, 2011
|Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator …|
S Garlapati, R Garg, R Brownlie, L Latimer, E Simko, REW Hancock, ...
Vaccine 30 (35), 5206-5214, 2012
|The potential of polyphosphazenes for delivery of vaccine antigens and immunotherapeutic agents|
NF Eng, S Garlapati, V Gerdts, A Potter, LA Babiuk, GK Mutwiri
Current drug delivery 7 (1), 13-20, 2010
|Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies|
M Polewicz, A Gracia, S Garlapati, J Van Kessel, S Strom, SA Halperin, ...
Vaccine 31 (31), 3148-3155, 2013
|Strategies to link innate and adaptive immunity when designing vaccine adjuvants|
S Garlapati, M Facci, M Polewicz, S Strom, LA Babiuk, G Mutwiri, ...
Veterinary immunology and immunopathology 128 (1-3), 184-191, 2009
|PCPP (poly [di (carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune …|
S Garlapati, NF Eng, HL Wilson, R Buchanan, GK Mutwiri, LA Babiuk, ...
Vaccine 28 (52), 8306-8314, 2010
|PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens|
NF Eng, S Garlapati, V Gerdts, LA Babiuk, GK Mutwiri
Journal of immune based therapies and vaccines 8, 1-11, 2010
|van Drunen Littel-van den Hurk, S. Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG …|
S Garlapati, R Garg, R Brownlie, L Latimer, E Simko, RE Hancock, ...
Vaccine 30, 5206-5214, 2012
|Do we know the Th1/Th2/Th17 determinants of vaccine response?|
Expert Review of Vaccines 11 (11), 1307-1310, 2012
|Polyphosphazenes enhance mucosal and systemic immune responses in mice immunized intranasally with influenza antigens|
N F Eng, S Garlapati, K Lai, V Gerdts, GK Mutwiri
The Open Vaccine Journal 2 (1), 2009
S Akira, S Alam, JM Andrieu, JK Andrus, V Balamurugan, ...
Expert Rev. Vaccines 9 (7), 802, 2010
|Van Ranst M Varga S Venkatesan G Yogisharadhya R Zakay-Rones Z|
C Ambrose, S Arya, L Aurisicchio, V Balamurugan, R Belshe, G Berbers, ...
|Leitner W Li S Loadman R Lopalco P|
F Lori, A Bandell, A Caputo, P Chong, V Cioce, K Coelingh, F D’Ancona, ...